Infini Capital has confirmed that its business and investment operations “remain normal” following reports that Hong Kong authorities have launched an insider trading investigation involving multiple financial firms, accordoing to a report by Reuters.
Veteran macro trader Brent Cook has joined Fulcrum Asset Management as a portfolio manager, continuing a career that has taken him across major banks and hedge funds in Europe and Australia, according to a report by eFinancial careers.
Hedge funds and institutional investors are increasingly deploying complex derivatives strategies to navigate extreme cross-asset volatility triggered by the conflict involving Iran, according to a report by Bloomberg citing several market participants including Citigroup.
Ben Cohen has renewed his criticism of hedge fund influence over the ice-cream business following the appointment of a partner from activist Trian Fund Management to the board of Magnum Ice Cream Company, according to a report by The Times.
In Alternative Views, Hedgeweek® goes behind closed doors with those in the know to get the latest on hedge funds. In this episode we speak to Salvatore Cordaro, CEO of Investcorp-Tages.
In Alternative Views, Hedgeweek® goes behind closed doors with those in the know to get the latest on hedge funds. Today we speak to the CEO of Moreton Capital Partners, Les Finemore, who has recently launched a new commodities based
The Iran conflict has sent crude prices surging, split hedge fund performance and reignited the debate over commodities as a strategic allocation. Hedgeweek examines what the disruption means for the sector.
Hedge funds posted moderate gains in February while attracting solid net inflows, according to the latest data from SS&C Technologies Holdings, Inc, with the SS&C GlobeOp Hedge Fund Performance Index recorded a gross return of 0.59% in February.
Sydney-based asset manager Regal Partners Ltd suffered a setback on Friday after shares in one of its portfolio companies, Immutep Ltd, collapsed following the discontinuation of a clinical trial for a lung cancer treatment, according to a report by Bloomberg.
JPMorgan Chase and UBS ended prime brokerage services for Hong Kong hedge Infini Capital Management months before authorities publicly disclosed an insider trading investigation involving the firm, according to a report by the Business Times citing unnamed sources familiar with
